Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Cash from Investing Activities (2016 - 2026)

Champions Oncology has reported Cash from Investing Activities over the past 17 years, most recently at -$14000.0 for Q1 2026.

  • For Q1 2026, Cash from Investing Activities rose 66.67% year-over-year to -$14000.0; the TTM value through Jan 2026 reached -$555000.0, down 317.29%, while the annual FY2025 figure was -$389000.0, 53.47% up from the prior year.
  • Cash from Investing Activities for Q1 2026 was -$14000.0 at Champions Oncology, up from -$242000.0 in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $3000.0 in Q2 2024 and troughed at -$760000.0 in Q2 2023.
  • A 5-year average of -$331875.0 and a median of -$247500.0 in 2025 define the central range for Cash from Investing Activities.
  • Biggest five-year swings in Cash from Investing Activities: soared 100.39% in 2024 and later plummeted 8533.33% in 2025.
  • Year by year, Cash from Investing Activities stood at -$604000.0 in 2022, then skyrocketed by 86.92% to -$79000.0 in 2023, then dropped by 18.99% to -$94000.0 in 2024, then plummeted by 157.45% to -$242000.0 in 2025, then skyrocketed by 94.21% to -$14000.0 in 2026.
  • Business Quant data shows Cash from Investing Activities for CSBR at -$14000.0 in Q1 2026, -$242000.0 in Q4 2025, and -$46000.0 in Q3 2025.